RazaU,KhanamA,FurqanM, 2010.Risk profile for breast carcinoma and tumour histopathology of medical uninsured patients in Pakistan,JAMC 23 9 -14
TanwaniAK, 2009.Pattern of invasive ductal carcinoma of breast according to Nottingham Prognostic Index,Ann Pak Inst Med Sci 5 251 -4
FitzgibbonsPL,DillonDA,AlsabehR,BermanMA,HayesDF,HicksDG, 2014.Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast,Arch Pathol Lab Med 138 595 -601
FaheemM,MahmoodH,KhurramM,QasimU,IrfanJ, 2012.Estrogen receptor, progesterone receptor, and Her2neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan,Ecancer Medical Science 6 283 -
DekkerT,SmitV,HooijerG,Van de VijverM,MeskerW,TollenaarR, 2013.Reliability of core needle biopsy for determining ER and Her2 status in breast cancer,Ann Oncol 24 931 -7
BadarF,MahmoodS,FarazR,YousafA,Ain, 2015.Epidemiology of breast cancer at the Shaukat Khanum Memorial Cancer Hospital,J Coll Physicians Surg Pak 25 738 -42
BouchbikaZ,BenchakrounN,TalebA,JouhadiH,TawfiqN,SahraouiS, 2012.Association between over expression of Her-2 and other clinicopathologic prognostic factors in breast cancer in Morocco,J Cancer Ther 3 787 -92
DeshpandeAK,ErukkambattuJ,PrabhalaS,Tanikella R. ER PR, 2015.Her2/neu markers carcinoma breast immunohistochemistry. Expression of estrogen, progesterone and Her2/neu receptors in breast carcinoma-study in a tertiary care hospital,JEMDS 4 10170 -7
MohammadianK,PashakiAS,HamedEA,BehnoodS,AbassiM,BabaeiM, 2014.Association between immunohistochemical profile and clinicopathological appearance in breast cancer: A 7-year review from Mahdieh Radiotherapy Center,Iran. Rep Radiother Oncol 1 103 -7
TamakiK,SasanoH,IshidaT,MiyashitaM,TakedaM,AmariM, 2010.Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and Her2 status of breast cancer patients,Cancer Sci 101 2074 -9
NwaforCC,KeshinroSO, 2015.Pattern of hormone receptors and human epidermal growth factor receptor 2 status in subSaharan breast cancer cases: Private practice experience,Niger J Clin Pract 18 553 -8
AndersCK,JohnsonR,LittonJ,PhillipsM,BleyerA, 2009.Breast cancer before age 40 years,Semin Oncol 36 237 -49
AmbroiseM,GhoshM,MallikarjunaV,KurianA, 2011.Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India,Asian Pac J Cancer Prev 12 625 -9
BhagatVM,JhaBM,PatelPR, 2012.Correlation of hormonal receptor and Her-2/neu expression in breast cancer: A study at tertiary care hospital in South Gujarat,Nat J Med Res 2 295 -8
PatnayakR,JenaA,RukmangadhaN,ChowhanAK,SambasivaiahK,PhaneendraBV, 2015.Hormone receptor status (estrogen receptor, progesterone receptor), human epidermal growth factor-2 and p53 in South Indian breast cancer patients: A tertiary care center experience,Indian J Med Paediatr Oncol 36 117 -22
Vona-DavisL,RoseDP,HazardH,Howard-McNattM,AdkinsF,PartinJ, 2008.Triple-negative breast cancer and obesity in a rural Appalachian population,Cancer Epidemiol Biomarkers Prev 17 3319 -24
AlluriP,NewmanLA, 2014.Basal-like and triple-negative breast cancers: Searching for positives among many negatives,Surg Oncol Clin N Am 23 567 -77
OnitiloAA,EngelJM,GreenleeRT,MukeshBN, 2009.Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival,Clin Med Res 7 4 -13
VoinescuDC,CiobotaruOR,SinA,BarnaO,ComanM,CiobotaruOC, 2015.Study of Her2, ER and PR markers and survival in invasive ductal carcinoma patients in south-east Romania,Biotechnol Biotechnol Equip 29 1135 -41
YouldenDR,CrambSM,YipCH,BaadePD, 2014.Incidence and mortality of female breast cancer in the Asia-Pacific region,Cancer Biol Med 11 101 -15
LeongSP,ShenZZ,LiuTJ,AgarwalG,TajimaT,PaikNS, 2010.Is breast cancer the same disease in Asian and Western countries?,World J Surg 34 2308 -24
GhoshJ,GuptaS,DesaiS,ShetT,RadhakrishnanS,SuryavanshiP, 2011.Estrogen, progesterone and Her2 receptor expression in breast tumors of patients, and their usage of Her2-targeted therapy, in a tertiary care centre in India,Indian J Cancer 48 391 -6
SajidMT,AhmedM,AzharM,MustafaQU,ShukrI,AhmedM, 2014.Age-related frequency of triple negative breast cancer in women,J Coll Physicians Surg Pak 24 400 -3
McGuireA,BrownJA,MaloneC,McLaughlinR,Kerin MJ, 2015.Effects of age on the detection and management of breast cancer,Cancers 7 908 -29
SivakumarP,RaviC, 2015.Breast cancer in young women: The effect of age on tumor biology and prognosis,Clin Cancerinvestig J 4 165 -9